Clinical Trial

Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective specimen collection study evaluating the feasibility of using the ChromoSeq® assay for upfront classification in a real-time clinical setting of pediatric and young adult acute lymphoid leukemia (ALL) patients. Sixty patients will undergo collections of bone marrow and/or peripheral blood for the ChromoSeq® assay at time of initial workup, and the patients will then be followed for clinical outcomes for up to 65 months.
Protocol Amendment History 5 changes
critical Recruitment opened 2026-06-11
notable Primary completion pushed: 2028-06-15 -> 2028-07-15 2026-06-11
minor Completion pushed: 2028-06-15 -> 2028-07-15 2026-06-11
notable Primary completion pushed: 2028-03-15 -> 2028-06-15 2026-04-14
minor Completion pushed: 2028-03-15 -> 2028-06-15 2026-04-14
Trial Details
NCT Number NCT07313592
Lead Sponsor Washington University School of Medicine
Collaborators: McDonnell Center
Conditions Acute Lymphoblastic Leukemia
Enrollment 60 participants
Start Date 2026-06-03
Primary Completion 2028-07-15 (estimated)
Study Completion 2028-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-10